Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News bioAffinity Technologies Inc BIAF

Healthcare Medical Instruments & Supplies
bioAffinity Technologies, Inc. is a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease. The Company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatment. Its segments include Diagnostic Research and Development (R&D) and Laboratory Services. Its... see more

Recent & Breaking News (NDAQ:BIAF)

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Accesswire January 5, 2024

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

Business Wire December 5, 2023

CMS Posts Final Payment Determination for bioAffinity Technologies' CyPath® Lung Effective January 2024

Business Wire November 30, 2023

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

Business Wire November 28, 2023

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

Business Wire November 15, 2023

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire November 14, 2023

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

Business Wire November 6, 2023

bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference

Business Wire October 10, 2023

bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

Business Wire September 19, 2023

bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference

Business Wire September 7, 2023

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update

Business Wire August 14, 2023

AMA Issues CPT Code for bioAffinity Technologies' CyPath® Lung Test for Early-Stage Lung Cancer

Business Wire July 12, 2023

bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium

Business Wire June 15, 2023

bioAffinity Technologies Presents Research Findings at CYTO 2023

Business Wire May 22, 2023

bioAffinity Technologies Reports First Quarter 2023 Financial Results

Business Wire May 15, 2023

bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer

Business Wire May 1, 2023

bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium

Business Wire April 25, 2023

bioAffinity Technologies to Ring Nasdaq Closing Bell Today

Business Wire April 5, 2023

bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results

Business Wire March 31, 2023

bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer

Business Wire March 28, 2023